DELTA-PIA - Controlled Discontinuation of Levothyroxine in Subclinical Hypothyroidism скачать в хорошем качестве

DELTA-PIA - Controlled Discontinuation of Levothyroxine in Subclinical Hypothyroidism

Session title: DELTA-PIA - Controlled Discontinuation of Levothyroxine in Subclinical Hypothyroidism - A Participatory Intervention Approach Moderators: Prof. Achim Mortsiefer and Prof. Petra Thürmann Hosted by: German Deprescribing Network Presenter: Dr. Karen Voigt is Head of the Department of Research in General Practice at the Department of General Practice, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, Germany Description: This session focuses on the controlled discontinuation of levothyroxine in patients with subclinical hypothyroidism. The speaker will present a deprescribing intervention built on participatory development (DELTA-PIA study) which was conducted in Germany from 2023 to 2025. Themes presented: Facilitators and barriers to controlled discontinuation of levothyroxine from patient & physician perspectives, and Strategies to increase patient & physician participation in the development of deprescribing studies. About the International Deprescribing Journal Club The Canadian Medication Appropriateness and Deprescribing Network works with international partners to host the journal club’s quarterly sessions. This journal club is for clinicians and researchers around the globe looking to connect and discuss recent deprescribing publications and complex clinical cases. Goals of the International Deprescribing Journal Club Strengthen partnerships among international deprescribing networks Stay current with the literature and share knowledge Build momentum and collaboration to facilitate larger international deprescribing trials showing impacts of deprescribing Session topics & format Content includes deprescribing case studies, recent literature, or a combination of both Sessions last approximately 50 to 60 minutes, including a minimum of 20 minutes of Q&A Sessions are recorded and posted on the Canadian Medication Appropriateness and Deprescribing Network’s YouTube channel.